贝佩多酸对因克雷丁轴和全身和肝炎的影响:一个试点,单心研究
Chiara Rovera1, Alice Del Zoppo1, Giovanni Petralli1
1Department of Surgical Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy.
Nutrition, metabolism, and cardiovascular diseases : NMCD
|October 10, 2025
概括
佩多酸 (Bemp-Ac) 有效降低LDL胆固醇,并减少对他类药物不耐受的人的肝炎和胆固醇症. 它还通过降低GLP-1和胰岛素水平,影响葡萄糖代谢.
科学领域:
- 心血管医学 心血管医学
- 代谢障碍 代谢障碍 代谢障碍
- 肝病学 肝病学是一种肝病学.
背景情况:
- 佩多酸 (Bemp-Ac) 是当他类药物不能耐受时高胆固醇血症的第一线治疗方法.
- 它有效地降低了LDL胆固醇和心血管事件.
- 它的抗炎和代谢作用需要在非糖尿病人身上进一步研究.
研究的目的:
- 探索佩多酸 (Bemp-Ac) 的疗效,耐受性和抗炎作用.
- 评估其对代谢特征,葡萄糖代谢荷尔蒙和肝脏健康的影响.
- 为了比较这些效应与Ezetimibe在他类药物不耐受,非糖尿病个体.
主要方法:
- 一项为期三个月的研究,涉及25名对他类药物不耐受的受试者,接受了Bempedoic Acid (Bemp-Ac) 180 mg/天的治疗.
- 通过Fibroscan测量了新陈代谢特征,调节葡萄糖的激素,炎症标志物和肝脏状况.
- 使用了12名接受10毫克/天埃泽蒂米布治疗的受试者的比较数据.
主要成果:
- 孟佩多酸 (Bemp-Ac) 降低了大约25%的总胆固醇,而不会影响功能.
- 肝脏状况显著改善 (减少CAP和LS) 和减少炎症标志物 (白细胞,细胞因子) 被观察到.
- 葡萄糖代谢分析显示GLP-1和胰岛素减少,而葡萄糖或GIP没有显著变化.
结论:
- 佩多酸 (Bemp-Ac) 显示出低脂性效应,同时减少了肝硬化和炎症.
- 该药物调节葡萄糖调节激素,特别是降低GLP-1和胰岛素.
- 这些发现凸显了Bemp-Ac在对他类药物不耐受,非糖尿病患者的多方面的益处.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
587
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
587
Inflammatory Bowel Disease IV: Pharmacological Management
517
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
517
Glucagon-like Receptor Agonists
841
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
841
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Bioavailability Study Design: Healthy Subjects Versus Patients
143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Acute Pancreatitis I: Introduction
1.1K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.1K

